Created in 2014 (United States), ALYFTEO own 18 sister brands and 2214 competing brands. ALYFTEO is owned by Vertex Pharma, listed on the stock exchange of New York ALYFTEO is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Vertex Pharma
(ALYFTEO)
over 5 years*
USD 932.47